Stay updated on Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page
- Check2 days agoChange DetectedA site-wide banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check9 days agoChange DetectedThe site's footer revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; no study record content is shown.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the usual study details. This indicates an access issue rather than content changes.SummaryDifference16%

- Check59 days agoChange DetectedThe page now shows Revision: v3.6.6 instead of v3.6.5, indicating a small backend or UI update. This change does not modify the displayed study information or user-facing content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small update to the page's template or documentation rather than any changes to study details.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.